Table II.
Main data of the included studies.
| Authors, year | No. of cases | Sex | PC | Tumor original location, n | Histology | PCI | CC | OS | Morbidity, % | Mortality, % | Refs. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tentes et al, 2016 | 33 | 14 M, 19 F | No | Head, 26; body, 2; tail, 4; mixed, 1 | adenoCa | n/a | n/a | 5-year: 24%. | 24.2 | 6.1 | (34) |
| Tentes et al, 2018a | 6 | 3 M, 3 F | Yes - 2 synchronous, 4 metachronous | Tail, 6 | adenoCa | 3–23 | CC-0 n=6; CC-1 n=1; CC-3 n=1 | 4–36 mo | 66.67 | 33.3 | (35) |
| Farma et al, 2005 | 7 | N/A | Yes - 3 synchronous, 4 metachronous | Head, 2; tail, 1; N/A, 4 | adenoCa | N/A | CC-0 n=6; CC-2 n=1 | 2–62 mo | 57 | 0 | (36) |
| Fujimura et al, 1999 | 1 | M | Yes - metachronous | N/A | adenoCa | N/A | N/A | 18 mo | 0 | 0 | (37) |
a
This study included 6 patients who underwent 8 procedures in total. M, male; F, female; PC, peritoneal carcinomatosis; adenoCa, adenocarcinoma; OS, overall survival; PCI, peritoneal carcinomatosis index; CC, completeness of cytoreduction; mo, months; n/a, not applicable; N/A, not available.